Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully

Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug... Int Urol Nephrol (2017) 49:1637–1643 DOI 10.1007/s11255-017-1627-6 NEPHROLOGY - ORIGINAL PAPER Fosfomycin for the treatment of drug‑resistant urinary tract infections: potential of an old drug not explored fully 1 1 Vrushali Patwardhan · Sarman Singh Received: 18 January 2017 / Accepted: 19 May 2017 / Published online: 14 June 2017 © Springer Science+Business Media Dordrecht 2017 Abstract Gram-positive isolates [698/707 (96%)] and MRSA [61/69 Introduction Increased emergence of bacterial resistance (88.4%)] were susceptible to fosfomycin. and the limited options of novel antimicrobial agents have Conclusions Fosfomycin showed an excellent in vitro necessitated the reintroduction of some old antimicrobial activity against all urinary pathogens, including the Gram- agents. One such drug is fosfomycin, but its potential has positive or Gram-negative, ESBL and MBL producers. Fos- not been explored fully, especially in India. fomycin should be considered as a highly effective alterna- Aims and objectives To analyze the in vitro activity of fos- tive in treatment UTIs in both adults and pediatric patients. fomycin, against the urinary isolates and to compare it with in vitro activity of other orally administered antimicrobial Keywords Uropathogens · Fosfomycin · EMBL · ESBL agents. Materials and methods This was a prospective observa- tional study conducted http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urology and Nephrology Springer Journals

Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully

Loading next page...
 
/lp/springer_journal/fosfomycin-for-the-treatment-of-drug-resistant-urinary-tract-ELsUUSPLUS
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media Dordrecht
Subject
Medicine & Public Health; Nephrology; Urology
ISSN
0301-1623
eISSN
1573-2584
D.O.I.
10.1007/s11255-017-1627-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial